StockGlow

Drugs Made In America Acquisition II Corp. (DMII)

Drugs Made In America Acquisition II Corp.

$10.12+0.00%Financial Services
Compare DMII with
StockGlow Score
79
Leaning Bullish
BearishBullish
1 year ago+2.4%

The outlook

Drugs Made In America Acquisition II Corp. currently reads as leaning bullish based on above its 50- & 200-day averages, 76% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range76% of the way from its 52-week low to high
Market cap
$644.6M
52-wk high
$10.20
52-wk low
$9.86
50-day avg
$10.08
200-day avg
$10.00
Trailing P/E
77.8

Similar stocks

CEPVCantor Equity Partners V, Inc.$10.40+0.00%CEPFCantor Equity Partners IV, Inc.$10.41+0.00%EVACEQV Ventures Acquisition Corp. II$10.24+0.10%KFIIK&F Growth Acquisition Corp. II$10.60+0.00%CRAQCal Redwood Acquisition Corp.$10.35+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy